Skip to main content
Erschienen in: Reactions Weekly 1/2022

01.10.2022 | Case report

Osimertinib

Radiation pneumonitis: 2 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Banla LI, et al. Risk of Radiation Pneumonitis in Patients Receiving Osimertinib and Thoracic Radiotherapy. International Journal of Radiation Oncology, Biology, Physics 114 (Suppl.): No. 3, 2022. Available from: URL: https://www.redjournal.org/ [abstract] Banla LI, et al. Risk of Radiation Pneumonitis in Patients Receiving Osimertinib and Thoracic Radiotherapy. International Journal of Radiation Oncology, Biology, Physics 114 (Suppl.): No. 3, 2022. Available from: URL: https://​www.​redjournal.​org/​ [abstract]
Metadaten
Titel
Osimertinib
Radiation pneumonitis: 2 case reports
Publikationsdatum
01.10.2022
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2022
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-022-25564-4

Weitere Artikel der Ausgabe 1/2022

Reactions Weekly 1/2022 Zur Ausgabe

Case report

Antineoplastics

Case report

Multiple drugs

Case report

Dexamethasone